Introduction {#s1}
============

Exposure to fine particulate matter with aerodynamic diameter $\leq 2.5\,\mu m$ (${PM}_{2.5}$) correlates with increased risk for type 2 diabetes mellitus and various abnormalities in glucose homeostasis ([@c4]; [@c29]; [@c28]). However, how ${PM}_{2.5}$ exposure promotes the development of abnormal glucose homeostasis remains to be determined ([@c11]). Putative mechanisms for this include: *a*) extrapulmonary translocation of ${PM}_{2.5}$ components; *b*) autonomic nervous system (ANS) dysfunction; and *c*) egress from the pulmonary inflammatory response ([@c36]). The evidence is strongest for egress from the pulmonary inflammatory response. Specifically, many studies have demonstrated that exposure to ${PM}_{2.5}$ causes pronounced pulmonary inflammation in humans (e.g., [@c14]; [@c23]) and in animal models (e.g., [@c15]; [@c16]), and a time course study revealed that ${PM}_{2.5}$ exposure-induced pulmonary inflammation preceded adverse extrapulmonary effects, such as systemic inflammation ([@c6]). As it is a consensus that systemic inflammation plays a crucial role in the pathogenesis of type 2 diabetes mellitus, pulmonary inflammation is postulated to be central to the pathogenesis of abnormal glucose homeostasis due to exposure to ${PM}_{2.5}$ ([@c5]). Consistent with this notion, we recently showed that pulmonary inflammation subsequent to lung epithelial cell-specific overexpression of constitutively active inhibitor $\kappa B$ kinase 2 (IKK2ca) was sufficient to induce marked insulin resistance ([@c7]). However, we also found that 5 wk of withdrawal from exposure to ${PM}_{2.5}$ resolved ${PM}_{2.5}$ exposure--induced extrapulmonary inflammation, vascular dysfunction, and hypertension, but not pulmonary inflammation ([@c44]), suggesting that a mechanism other than pulmonary inflammation may also be involved in ${PM}_{2.5}$ exposure--induced systemic inflammation or abnormalities in glucose homeostasis. Further studies are thus needed to pinpoint the role of pulmonary inflammation in the development of adverse effects due to ${PM}_{2.5}$ exposure.

IKK2 regulates nuclear factor-kappaB ($\text{NF\ -}\kappa B$) activity and plays a crucial role in both acute and chronic inflammations ([@c35]). Studies have shown that exposure to ${PM}_{2.5}$ activates the $\text{IKK}2/\text{NF\ -}\kappa B$ pathway in various tissues, including the lung ([@c10]; [@c20]; [@c30]; [@c32]; [@c33]). Furthermore, inhibition of IKK2 blocked ${PM}_{2.5}$ exposure--induced expression of inflammatory cytokines in respiratory epithelial cells ([@c25]) and alveolar macrophages ([@c20]), suggesting that targeting pulmonary IKK2 might disconnect ${PM}_{2.5}$ exposure and pulmonary inflammation. In the present study, we therefore generated lung epithelial cell--specific IKK2-deficient mice ($\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{+ / -}\text{IKK}2^{\text{flox}/\text{flox}}$) and used them to ascertain the role of pulmonary inflammation in the pathogenesis of insulin resistance due to exposure to diesel exhaust particulate matter (DEP).

Materials and Methods {#s2}
=====================

Animals {#s2.1}
-------

University of Maryland, Baltimore (UMB) is an AAALAC-accredited institution. All procedures in this study were approved by the Institutional Animal Care and Use Committee (IACUC) at UMB, and all the animals were treated humanely and with regard for alleviation of suffering. SFTPC-rtTA (Stock No. 016146) and tetO-cre (Stock No. 006224) transgenic mice were obtained from Jackson Laboratories. The generation of $\text{IKK}2^{\text{flox}/\text{flox}}$ mice were previously described ([@c31]). Male $\text{SFTPC\ -\ rtTA}^{+ / -}\text{tetO\ -cre}^{+ / -}\text{IKK}2^{\text{flox}/\text{flox}}$ (3 for [Figure 1B](#f1){ref-type="fig"}, 5 for [Figures 1C and 1D](#f1){ref-type="fig"}, 6 for instillation of PBS, and 7 for instillation of DEP) and male $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{- / -}\text{IKK}2^{\text{flox}/\text{flox}}$ littermates (3 for [Figure 1B](#f1){ref-type="fig"}, 5 for [Figures 1C and 1D](#f1){ref-type="fig"}, 7 for instillation of PBS, and 8 for instillation of DEP) were generated through crossing between $\text{SFTPC\ -rtTA}^{+ / +}\text{tetO\ -cre}^{+ / -}\text{IKK}2^{\text{flox}/\text{flox}}$ and $\text{IKK}2^{\text{flox}/\text{flox}}$. To induce the deletion of IKK2, after weaning, all the mice were fed with doxycycline in their diet ($625\;{mg}/{kg}$ diet, Envigo TD.01306) for 8 wk. Due to the concern about the doxycycline feeding as a potential confounding factor, all the mice in this study were not fed with the doxycycline diet beyond the 8 wk of doxycycline feeding. To prevent confusion, in the present study, these doxycycline diet--fed male $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{+ / -}\text{IKK}2^{\text{flox}/\text{flox}}$ mice and male $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{- / -}\text{IKK}2^{\text{flox}/\text{flox}}$ littermates are referred to as knockout (KO) and wildtype (tgWT) mice, respectively. All the mice were housed in standard cages (Super Mouse 1800™ Ventilated Racks & Cages; Lab Products, Inc.) with full access to diet \[either the doxycycline diet or Teklad global 14% protein (Envigo) diet, replaced weekly\] and water (replaced weekly). The room was kept with a 12-h light/12-h dark cycle, temperatures of 65 to 75°F, and 40 to 60% humidity. The mice used in the present study were weaned when 21--24 days old.

![Pulmonary inflammation after diesel exhaust particulate matter (DEP) treatment in mice with lung epithelial cell-specific IKK2 deficiency. (A) The experimental scheme. a, genotyping; b, weaning and initiation of doxycycline (Dox) feeding; c, assessments of induced knockout by PCR and Western blotting; d, initiation of phosphate buffered saline (PBS)/DEP instillation; e, euthanizing and tissue-harvesting. (B) $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{+ / -}\text{IKK}2^{\text{flox}/\text{flox}}$ (knockout, KO) and littermate control ($\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{- / -}\text{IKK}2^{\text{flox}/\text{flox}}$, transgenic wild-type control, tgWT) were fed with a doxycycline diet ($625\;{mg}/{kg}$ diet) for 8 wk. Subgroups of these mice were immediately euthanized, the indicated tissues were isolated and their deletion of IKK2 was assessed by PCR. A representative result is presented. Of all those tested mice ($n = 3/\text{group}$), no evident outlier in any group was noted. K, KO; W, tgWT. The scale marker equals $1\;{cm}$. (C and D) KO and littermate control (tgWT) were euthanized immediately after the 8-wk feeding with a doxycycline diet ($625\;{mg}/{kg}$ diet), and their lungs were isolated and subjected to Western blotting analysis of IKK2 protein expression. A representative image (C) and quantitation of results as a percentage of the $\beta\text{-actin}$ loading control (D) are presented. $n = 5/\text{group}$. \*$p < 0.05$ vs. tgWT, Student's *t* test. (E--L) KO and tgWT mice were subjected to a 4-month intratracheal instillation of either PBS or DEP. After euthanasia, BALF cells were differentiated (E--I). Levels of the indicated cytokines in those BALFs were assessed using the BD Cytometric Bead Array Kit (J--L). $n = 6–8/\text{group}$. All data were expressed as $\text{means} \pm \text{SEMs}$. \*$p < 0.05$ vs. PBS, ^\#^$p < 0.05$ vs. tgWT, two-way ANOVA followed by Bonferroni correction.](ehp-127-057009-g0001){#f1}

PCR Genotyping and Confirming the Deletion of IKK2 by the Doxycycline Feeding {#s2.2}
-----------------------------------------------------------------------------

All one-week-old newborns were subjected to tail biopsying, and the genomic DNA were extracted from those biopsies. The genotype of each mouse was determined by polymerase chain reaction (PCR), using the genotyping primers ([Table 1](#t1){ref-type="table"}). The PCR cycling parameters included: 4 min predenaturing at 94°C and 35 cycles of 30-s denaturing at 94°C, 30-s annealing at 60°C, and 60-s extension at 72°C. Before PBS/DEP instillation, all the mice were genotyped again as described above to verify their genotypes. To confirm the induced deletion of IKK2 by the doxycycline feeding, three tgWT and three KO were euthanized at the end of the doxycycline feeding, and the genomic DNA were extracted from the heart, liver, lung, and kidney. The WT, floxed, and $\Delta$ alleles were visualized by PCR using the deletion-confirming primers in [Table 1](#t1){ref-type="table"} (obtained from Sigma-Aldrich). The above-mentioned PCR cycling parameters were applied.

###### 

Primer sequences for RT-PCR.

Table 1 lists certain gene factors in the first column and the adjacent columns list forward primer and reverse primer.

                                                               Forward primer              Reverse primer
  ------------------------------------------------------------ --------------------------- ----------------------------------
  F4/80                                                        TGTCTGACAATTGGGATCTGCCCT    TTGCATGTTCAGGGCAAACGTCTC
  GAPDH                                                        GCAGTGGCAAAGTGGAGATTGTTGC   CCCGTTGATGACAAGCTTCCCATTC
  IL-6                                                         ATCCAGTTGCCTTCTTGGGACTGA    TAAGCCTCCGACTTGTGAAGTGGT
  $\text{TNF}\alpha$                                           TTCCGAATTCACTGGAGCCTCGAA    TGCACCTCAGGGAAGAATCTGGAA
  $\text{IL-1}\beta$                                           ACGGACCCCAAAAGATGAAG        TTCTCCACAGCCACAATGAG
  MCP1                                                         GCTCAGCCAGATGCAGTTAA        TCTTGAGCTTGGTGACAAAAACT
  IKK2 deletion-confirming[^*a*^](#TF1){ref-type="table-fn"}   CGCCTAGGTAAGATGGCTGTCT      Primer 1: GTGGTCATAGGTCTGGTTGTCC
  Primer 2: TAGTCCAACTGGCAGCGAATAC                                                         
  IKK2 genotyping[^*b*^](#TF2){ref-type="table-fn"}            GTCATTTCCACAGCCCTGTGA       CCTTGTCCTATAGAAGCACAAC
  SFTPC-rtTA genotyping                                        CGCTGTGGGGCATTTTACTTTAG     CATGTCCAGATCGAAATCGTC
  Cre genotyping                                               ACCTGATGGACATGTTCAGGGATCG   TCCGGTTATTCAACTTGCACCATGC

To confirm the deletion of IKK2 by the treatment with doxycycline, three primers were used and visualized all three alleles (WT, floxed, and recombinant \[$\Delta$\]) in one PCR reaction.

To genotype the IKK2 gene, two primers were used and visualized the WT and floxed alleles only.

DEP Intratracheal Instillation {#s2.3}
------------------------------

DEP was obtained from the National Institute of Standards and Technology (DEP, NIST® SRM® 2975). The chemical characterization of this DEP is available at [www-s.nist.gov/srmors/certificates/2975.pdf](http://www-s.nist.gov/srmors/certificates/2975.pdf). Its mean diameter of particles was $1.62 \pm 0.01\;\mu m$. It was stored at 4°C and kept away from direct sunlight. To perform instillation, DEP was suspended in sterile phosphate-buffered saline (PBS). To minimize aggregation, DEP suspensions were sonicated (Clifton Ultrasonic Bath) for 20 min on the day of instillation and vortexed 30 s before each instillation. The instillation of DEP was initiated when mice were 12--14 wk old (1--2 wk after 8-wk feeding of the doxycycline diet). The KO and tgWT mice were housed mixedly, and each cage was randomly allocated to either PBS or DEP instillation. The instillation of DEP was performed as previously described ([@c24]), with minor modifications. Briefly, to instill DEP, the animals were anesthetized with 3% isoflurane and placed supine with extended necks on an angled board. A Becton Dickinson 18 Gauge cannula was inserted via the mouth into the trachea. DEP suspension ($20\;\mu g$ in $50\;\mu l$, approximately equating to inhalational exposure to $160{\,\mu g/m}^{3}$ ${PM}_{2.5}$) ([@c3]) or PBS ($50\;\mu l$) were intratracheally instilled via a sterile syringe and followed by an air bolus of $150\;\mu l$. The intubation catheter was removed and the mouse transferred to a vertical hanging position with the head up for 5 min, ensuring that the delivered material was maintained in the lung and did not block the airways. Either DEP or PBS was instilled 3 times per week (Monday, Wednesday, and Friday) for 19 wk.

Intraperitoneal Glucose Tolerance Test (IPGTT) and Glucose-Induced Insulin Secretion Assessment {#s2.4}
-----------------------------------------------------------------------------------------------

IPGTT was performed monthly (on the fourth Tuesday of each month) during the 4-month exposure to DEP. Before testing, mice were fasted for 16 h. The blood of mouse tail vein was collected through a small cut to determine the blood glucose level. On the day of the experiments, after determination of basal (0 min) blood glucose level using an automatic glucometer (Glucotrend 2, Roche Diagnostics), mice were intraperitoneally injected with glucose \[$2\; g/{kg}$ body weight (BW)\]. Blood glucose levels at 15, 30, 60, and 120 min after injection of glucose were then measured using the automatic glucometer. When performing the last IPGTT (4-month exposure), sera at 0, 15, and 30 min were harvested, and their insulin levels were determined using Ultra Sensitive Mouse Insulin ELISA Kit (Crystal Chem, Inc.) per the manufacturer's instructions. To harvest the sera, the blood of mouse tail vein was allowed to clot for 30 min at room temperature, and then centrifuged at $10,000\text{ \ rpm}$ and 4°C for 10 min. The supernatants were transferred to new tubes and kept at $- 80{^\circ}C$ until the assessment of insulin.

Insulin Tolerance Test (ITT) {#s2.5}
----------------------------

ITT was performed (one week after the last IPGTT) after the 4-month exposure to DEP. Before testing, mice were fasted for 4 h. The blood of mouse tail vein was collected through a small cut for determining the blood glucose level. After determination of basal blood glucose level using an automatic glucometer (Glucotrend 2), mice were intraperitoneally injected with insulin ($0.5\; U/{kg}$ BW). Blood glucose levels at 15, 30, 60, and 120 min after injection of insulin were then measured as described above.

Animal Euthanasia, Bronchoalveolar Lavage, and Tissue Harvesting {#s2.6}
----------------------------------------------------------------

Animals were fasted overnight and injected intraperitoneally with insulin ($10\; U/{kg}$ BW). This high dose of insulin is generally used for assessing insulin-induced Akt phosphorylation in the insulin-responsive tissues ([@c22], [@c21]). After 20 min, animals were euthanized by overdose of isoflurane. Blood was collected from the heart and centrifuged at $3,000\text{ \ rpm}$ for 5 min. Plasma and all other tissues (liver, epididymal adipose tissue, and skeletal muscle) were immediately stored first in dry ice and then at $- 80{^\circ}C$ until further processing.

To perform bronchoalveolar lavage, the mouse lung, trachea, and heart were removed and put on ice. Through a tracheal cannula, $1\;{mL}$ sterile PBS with $0.1\text{ \ mM}$ ethylenediaminetetraacetic acid (EDTA) was instilled and withdrawn to recover bronchoalveolar lavage fluid (BALF). This lavage was performed three times in total. The total number of cells in the collected BALF (around $3\;{mL}$) was estimated using a hemocytometer. After 5 min centrifuge at $1,500\text{ \ rpm}$, the BALF were stored in dry ice and then $- 80{^\circ}C$ until further processing, and the precipitated cells were used for BALF cell differentiation. Cytospin slides were prepared using Shandon Cytospin 3™ (Thermo Scientific) and stained with Diff-Quik solution (EMS) per the manufacturers' protocols. Differential cell counts for neutrophils, eosinophils, macrophages, monocytes, and lymphocytes were assessed by a pathologist who was blinded to the grouping.

### Plasma and BALF cytokine analysis. {#s2.6.1}

Plasma and BALF cytokine levels were assessed using the flex set of BD™ Cytometric Bead Array Kit (BD Biosciences, Catalog No. 560232, 558301, and 558299) per the manufacturer's instructions. We assessed these three cytokines because they are the most frequently used markers for evaluating the inflammatory level. Briefly, $25\;\mu L\text{ \ per\ mouse}$ plasma were incubated with the beads, and the signaling was assessed by BD Canto II flow cytometry per the manual of the BD™ Cytometric Bead Array Kit. The $\text{TNF}\alpha$, interleukin $\left( \text{IL} \right)\text{-}1\beta$ ($\text{IL-1}\beta$, and IL-6 levels of each sample were then determined using the standard curves. To facilitate statistical analysis, the cytokine level of all samples measuring below the detection limit (provided by the manufacturer) was imputed to be the detection limit itself.

Western Blotting {#s2.7}
----------------

Lysates of liver, epididymal adipose tissue, and skeletal muscle were prepared using radioimmunoprecipitation assay (RIPA) buffer (MilliporeSigma) supplemented with protease and phosphatase inhibitors (Sigma, Catalog No. P2714 and P5726). Briefly, for each sample, a $\sim 5\;{mg}$ piece of tissue was cut on ice. Next, $\sim 300\;\mu L$ of ice-cold lysis buffer was added rapidly to the tube. The tissues were homogenized with Bead Ruptor Elite Bead Mill Homogenizer (OMNI International) for 5 min, then maintained with constant agitation for 30 min at 4°C. These lysates were then centrifuged for 20 min at $12,000\text{ \ rpm}$ at 4°C. The supernatants were transferred to fresh tubes on ice. The protein level for each sample was determined using Pierce™ BCA Protein Assay Kit (ThermoFisher). For each sample, $40\;\mu g$ protein was then separated by 10% SDS-polyacrylamide gel electrophoresis \[freshly prepared using the PROTEAN® II XL Cell system (Bio-Rad)\] and electroblotted onto polyvinylidene fluoride membranes (Immun-Blot PVDF Membrane; Bio-Rad, Catalog No. 1620177). The membrane was blocked using Amersham ECL Prime Blocking Reagent (Catalog No. RPN418) for 1 h at room temperature and then incubated with each of the following primary antibodies overnight at 4°C: 1:500 diluted Phospho-IRS-1 (Ser307) Antibody \#2381 (Cell Signaling Technology), 1:500 diluted Phospho-IRS-1 (Ser1101) Antibody \#2385 (Cell Signaling Technology), 1:1,000 diluted IRS-1 Antibody \#3194 (Cell Signaling Technology), 1:500 diluted Phospho-SAPK/JNK (Thr183/Tyr185) (G9) Mouse mAb \#9255 (Cell Signaling Technology), 1:1,000 diluted SAPK/JNK Antibody \#9252 (Cell Signaling Technology), 1:500 diluted $\text{Phospho\ -IKK}\alpha/\beta$ (Ser176/180) Antibody II \#2694 (Cell Signaling Technology), 1:1,000 diluted $\text{IKK}\beta$ (D30C6) Rabbit mAb \#8943 (Cell Signaling Technology), and 1:10,000 diluted Monoclonal $\text{Anti\ -}\beta\text{-Actin}$ Antibody A5316 (Sigma-Aldrich). After washing with TBST buffer 3 times (10 min per time), the membrane was incubated with 1:5,000 diluted secondary antibodies conjugated with horseradish peroxidase (Amersham, Catalog Nos. NA931-1ML and NA934-1ML) for 1 h at room temperature. After washing with TBST buffer 3 times (10 min per time), the target proteins were visualized with the chemiluminescence reagent (Amersham, Catalog No. RPN2232). The images were acquired using ImageQuant LAS 4000 (Amersham) per the manufacturer's instructions. Densities of target protein bands were determined with Quantity One® 1-D 4.4.1 Software (Bio-Rad).

Quantitative Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) {#s2.8}
---------------------------------------------------------------------

Total RNA was isolated from the livers with Invitrogen™ TRIzol™ reagent (Invitrogen) per the manufacturer's instructions. The RNA concentrations were determined using NanoDrop™ 2000/2000c Spectrophotometers (Thermo Fisher). Any sample with an OD260/OD280 ratio below 1.2 was not used. In addition, $2\;\mu g$ total RNA was reverse-transcribed using random hexamers and the ThermoScript™ RT-PCR System (Invitrogen). Quantitative real-time polymerase chain reaction (RT-PCR) was performed with a LightCycler® 480 Instrument II (Roche) and SYBER Green PCR Master Mix (Applied Biosystems). The sequences of primers are presented in [Table 1](#t1){ref-type="table"} and obtained from Sigma-Aldrich. The relative expression level was obtained as described previously ([@c43]). Briefly, Ct values were acquainted using the built-in software of LightCycler® 480 Instrument II, and differences of Ct value between target gene and GAPDH ($\Delta\text{Ct}$) and then $2^{\Delta\text{Ct}}$ were calculated.

Statistics {#s2.9}
----------

All data are expressed as $\text{means} \pm \text{Standard\ Error\ of\ the\ Means\  }\left( \text{SEMs} \right)$ unless noted otherwise. Statistical tests were performed using one-way or two-way analysis of variance (ANOVA) followed by Bonferroni correction or unpaired *t*-test using GraphPad Prism (version 5; GraphPad Software). The significance level was set at $p < 0.05$.

Results {#s3}
=======

Pulmonary Inflammation after DEP Treatment in Mice with Lung Epithelial Cell-Specific IKK2 Deficiency {#s3.1}
-----------------------------------------------------------------------------------------------------

To ascertain the role of pulmonary inflammation in ${PM}_{2.5}$ exposure--induced pathogenesis, we generated $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{+ / -}\text{IKK}2^{\text{flox}/\text{flox}}$ and littermate control ($\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{- / -}\text{IKK}2^{\text{flox}/\text{flox}}$) mice. PCR analysis showed that the 8-wk feeding with doxycycline diet resulted in marked IKK2 gene recombination in the lung, but not in the heart, liver, or kidney ([Figure 1B](#f1){ref-type="fig"}). This recombination of IKK2 gene in the lung was concurrent with significantly lower expression of pulmonary IKK2 protein ([Figures 1C and D](#f1){ref-type="fig"}).

To determine the effect of lung epithelial cell--specific IKK2 deficiency on ${PM}_{2.5}$-exposure--induced pulmonary inflammation, doxycycline diet--fed male $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{+ / -}\text{IKK}2^{\text{flox}/\text{flox}}$ (KO) and $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{- / -}\text{IKK}2^{\text{flox}/\text{flox}}$ littermates (tgWT) were subjected to 4-month intratracheal instillation of DEP or PBS. BALF cell counting revealed that DEP-instilled tgWT mice vs. PBS-instilled tgWT mice, but not DEP-instilled KO mice vs. PBS-instilled KO mice, had greater BALF total cell numbers ([Figure 1E](#f1){ref-type="fig"}), a frequently used indicator of pulmonary inflammation. BALF cell differentiation showed that DEP-instilled tgWT mice vs. PBS-instilled tgWT mice, but not DEP-instilled KO mice vs. PBS-instilled KO mice, had higher macrophages and lymphocytes in BALF ([Figures 1F--1G](#f1){ref-type="fig"}). BALF proinflammatory cytokine levels are also frequently used as indicators of pulmonary inflammation. BALF proinflammatory cytokine assessments showed that DEP-instilled tgWT mice had higher levels of BALF tumor necrosis factor $\alpha$ ($\text{TNF}\alpha$), $\text{IL-1}\beta$, and IL-6 than those of PBS-instilled tgWT mice ([Figures 1J--1L](#f1){ref-type="fig"}). The differences in the BALF proinflammatory cytokine levels between DEP-instilled and PBS-instilled KO mice were smaller than those between DEP-instilled and PBS-instilled tgWT mice ([Figures 1J--1L](#f1){ref-type="fig"}).

Levels of Circulating Proinflammatory Cytokines after DEP Treatment in Mice with Lung Epithelial Cell--Specific IKK2 Deficiency {#s3.2}
-------------------------------------------------------------------------------------------------------------------------------

We also assessed the levels of circulating proinflammatory cytokines. The assessments of circulating proinflammatory cytokines showed that DEP-instilled tgWT mice had higher levels of circulating $\text{TNF}\alpha$ and IL-6 than levels in PBS-instilled tgWT mice, whereas DEP-instilled KO mice had almost comparable levels of circulating $\text{TNF}\alpha$ and IL-6 in comparison with levels in PBS-instilled KO mice ([Figure 2](#f2){ref-type="fig"}).

![Levels of circulating pro-inflammatory cytokines after diesel exhaust particulate matter (DEP) treatment in mice with lung epithelial cell-specific IKK2 deficiency. Plasma were harvested after phosphate buffered saline (PBS) or DEP-treated mice were euthanized and levels of $\text{TNF}\alpha$ (A), interleukin-1β ($\text{IL-1}\beta$) (B), and IL-6 (C) were determined using the BD Cytometric Bead Array Kit. $n = 6–8/\text{group}$. All data were expressed as $\text{means} \pm \text{SEMs}$. \*$p < 0.05$ vs. PBS, ^\#^$p < 0.05$ vs. tgWT, two-way ANOVA followed by Bonferroni correction. KO, $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{+ / -}\text{IKK}2^{\text{flox}/\text{flox}}$ mice; tgWT, $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{- / -}\text{IKK}2^{\text{flox}/\text{flox}}$ littermates.](ehp-127-057009-g0002){#f2}

Glucose Metabolism in DEP-Exposed Mice with Lung Epithelial Cell--Specific IKK2 Deficiency {#s3.3}
------------------------------------------------------------------------------------------

To ascertain the time dependency of glucose metabolic effect of DEP exposure, IPGTT was performed monthly on these DEP- or vehicle-treated mice. The results of IPGTT revealed that after 3-month and 4-month exposures, DEP-exposed tgWT mice had significantly lower glucose tolerance in comparison with that of PBS-exposed tgWT mice, whereas DEP-exposed KO mice had almost comparable glucose tolerance in comparison with that of PBS-exposed KO mice ([Figures 3A--3H](#f3){ref-type="fig"}). Furthermore, ITT showed that, after the 4-month exposure, DEP-exposed tgWT mice had significantly higher glucose-induced insulin secretion in comparison with glucose-induced insulin secretion in PBS-exposed tgWT mice ([Figures 3I and 3J](#f3){ref-type="fig"}) and lower systemic insulin sensitivity ([Figures 3K and 3L](#f3){ref-type="fig"}). Coincident with the above-mentioned inflammation analyses, DEP-exposed KO mice had markedly smaller differences in glucose-induced insulin secretion in comparison with glucose-induced insulin secretion of PBS-exposed KO mice ([Figures 3I and 3J](#f3){ref-type="fig"}) and almost comparable sensitivity to insulin ([Figures 3K and 3L](#f3){ref-type="fig"}).

![Glucose metabolism in diesel exhaust particulate matter (DEP)-exposed mice with lung epithelial cell-specific IKK2 deficiency. (A--H) Intraperitoneal glucose tolerance test (IPGTT) was performed monthly when KO and tgWT mice were being subjected to phosphate buffered saline (PBS) or DEP instillation. Both the response curves (A, C, E, and G) and summarization of area under the curve (AUC, B, D, F, and H) are presented. (I and J) When performing the last IPGTT (4-month instillation), sera were collected at the indicated timepoints, and their insulin levels were determined. The response curves (I) and summarization of AUC (J) are presented. (K and L) Insulin tolerance test (ITT) was performed 1 wk after the last IPGTT. The response curves (K) and summarization of AUC (L) are presented. $n = 6–8/\text{group}$. All data were expressed as $\text{means} \pm \text{SEMs}$. \*$p < 0.05$ vs. PBS, ^\#^ $p < 0.05$ vs. tgWT, two-way ANOVA followed by Bonferroni correction. KO, $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{+ / -}\text{IKK}2^{\text{flox}/\text{flox}}$ mice; tgWT, $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{- / -}\text{IKK}2^{\text{flox}/\text{flox}}$ littermates.](ehp-127-057009-g0003){#f3}

Insulin Tolerance in DEP-Exposed Mice with Lung Epithelial Cell--Specific IKK2 Deficiency {#s3.4}
-----------------------------------------------------------------------------------------

To further document the mechanism whereby DEP exposure results in systemic insulin resistance, we assessed Akt phosphorylation level, a reflection of local insulin signaling ([@c13]), in insulin-sensitive tissues, including the liver, adipose tissue, and skeletal muscle. DEP-exposed tgWT mice had significantly lower insulin-induced Akt phosphorylation in the liver in comparison with that of PBS-exposed tgWT mice ([Figures 4A and 4B](#f4){ref-type="fig"}), but DEP-exposed tgWT mice and PBS-exposed tgWT mice had comparable insulin-induced Akt phosphorylation in the adipose tissue and skeletal muscle ([Figures 4A and 4B](#f4){ref-type="fig"}), suggesting that DEP exposure induces glucose intolerance primarily through induction of hepatic insulin resistance. Consistent with the investigation of systemic insulin resistance ([Figure 3](#f3){ref-type="fig"}), DEP-exposed KO mice and PBS-exposed KO mice had comparable Akt phosphorylation in the liver, adipose tissue, and skeleton muscle ([Figures 4A and 4B](#f4){ref-type="fig"}).

![Insulin sensitivity in diesel exhaust particulate matter (DEP)-exposed mice with lung epithelial cell-specific IKK2 deficiency. Before euthanasia, those phosphate buffered saline (PBS) or DEP-treated mice were injected intraperitoneally with insulin ($10\; U/{kg}$ body weight), and the insulin-responsive tissues, including liver, epididymal adipose tissue (AT), and skeleton muscle (SM), were isolated and subjected to western blot analysis of Akt phosphorylation. Representative images (A) and quantitation data (B) are presented. To quantitate the phosphorylation, the phosphor-Akt level was normalized to total Akt and graphed in relation to PBS/tgWT. $n = 6–8/\text{group}$. All data were expressed as $\text{means} \pm \text{SEMs}$. \*$p < 0.05$ vs. PBS, two-way ANOVA followed by Bonferroni correction. KO, $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{+ / -}\text{IKK}2^{\text{flox}/\text{flox}}$ mice; tgWT, $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{- / -}\text{IKK}2^{\text{flox}/\text{flox}}$ littermates.](ehp-127-057009-g0004){#f4}

Hepatic IRS-1 Phosphorylation and Inflammatory Response in DEP-Exposed Mice with Lung-Specific IKK2 Deficiency {#s3.5}
--------------------------------------------------------------------------------------------------------------

In line with the assessment of hepatic insulin signaling ([Figure 4](#f4){ref-type="fig"}), DEP-instilled tgWT mice had higher hepatic IRS-1 Ser307 and Ser1101 phosphorylation levels in comparison with levels in PBS-instilled tgWT mice, whereas DEP-instilled KO mice and PBS-instilled KO mice had comparable hepatic IRS-1 serine phosphorylation ([Figures 5A and 5B](#f5){ref-type="fig"}). To determine whether a local inflammatory response mediates DEP exposure inducing hepatic insulin resistance, we assessed hepatic activities of IKK2 and c-Jun $\text{NH}_{2}\text{-terminal}$ kinase (JNK), two central regulators of the inflammatory response. Our results revealed that DEP-instilled tgWT mice had significantly higher phosphorylation levels of IKK2 and JNK in comparison with those levels in PBS-instilled tgWT mice ([Figures 5C and 5D](#f5){ref-type="fig"}), suggesting that both hepatic IKK2 and JNK signaling pathways are activated by exposure to DEP. Furthermore, we found that DEP-instilled KO mice and PBS-instilled KO mice had comparable hepatic IKK2 and JNK phosphorylation levels. Consistent with the analyses of IKK2 and JNK activity, quantitative PCR analyses revealed that DEP-instilled tgWT mice had significantly higher hepatic mRNA expression levels of $\text{TNF}\alpha$, $\text{IL-1}\beta$, IL-6, monocyte chemoattractant protein 1 (MCP-1), and the mouse macrophage marker F4/80 than expression levels found in PBS-instilled tgWT, whereas DEP-instilled KO mice and PBS-instilled KO had comparable $\text{IL} - 1\beta$ and IL-6 mRNA expression ([Figure 6](#f6){ref-type="fig"}); additionally, the differences in the expression levels of $\text{TNF}\alpha$, MCP-1, and F4/80 were also markedly lower than those between DEP-instilled tgWT mice and PBS-instilled tgWT mice ([Figure 6](#f6){ref-type="fig"}).

![Hepatic IRS-1 phosphorylation and inflammatory response in diesel exhaust particulate matter (DEP)-exposed mice with lung epithelial cell-specific IKK2 deficiency. Western blotting analysis was used to determine hepatic IRS-1 Ser307 and Ser1101 phosphorylation levels (A and B) and hepatic IKK2 and JNK phosphorylation levels (C and D). The representative images (A and C) and quantitation data (B and D) are presented. To quantitate the phosphorylation, the phosphor-IRS-1, phosphor-IKK2, and phosphor-JNK levels was normalized to total IRS-1, IKK2, and JNK, respectively, and graphed in relation to phosphate buffered saline (PBS)/tgWT. $n = 6–8/\text{group}$. All data were expressed as $\text{means} \pm \text{SEMs}$. \*$p < 0.05$ vs. PBS, ^\#^ $p < 0.05$ vs. tgWT, two-way ANOVA followed by Bonferroni correction.](ehp-127-057009-g0005){#f5}

![Hepatic proinflammatory cytokine expression levels in diesel exhaust particulate matter (DEP)-exposed mice with lung epithelial cell-specific IKK2 deficiency. Hepatic expression of the indicated inflammatory biomarkers was determined by real-time quantitative PCR (RT-PCR). $n = 6–8/\text{group}$. All data were expressed as $\text{means} \pm \text{SEMs}$. \*$p < 0.05$ vs. PBS, ^\#^ $p < 0.05$ vs. tgWT, two-way ANOVA followed by Bonferroni correction. KO, $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{+ / -}\text{IKK}2^{\text{flox}/\text{flox}}$ mice; tgWT, $\text{SFTPC\ -rtTA}^{+ / -}\text{tetO\ -cre}^{- / -}\text{IKK}2^{\text{flox}/\text{flox}}$ littermates. PBS, phosphate buffered saline.](ehp-127-057009-g0006){#f6}

Discussion {#s4}
==========

Compelling evidence has demonstrated that exposure to ${PM}_{2.5}$ correlates with various abnormalities in glucose homeostasis and increased risk for type 2 diabetes mellitus ([@c4]; [@c29], [@c28]). Pulmonary inflammation is believed to be central to the development of adverse health effects due to exposure to ${PM}_{2.5}$ ([@c36]), such as abnormal glucose homeostasis. This role of pulmonary inflammation, however, had not yet been systemically investigated. To ascertain the role of pulmonary inflammation in the pathogenesis due to exposure to ${PM}_{2.5}$, the present study used SPFTC-rtTA and tetO-cre alleles to knock out IKK2 specifically in lung epithelial cells, and assessed how this genetic manipulation affected DEP exposure--induced pulmonary inflammation and abnormalities in glucose homeostasis. The major findings in this study suggest that: *a*) lung epithelial cell-specific IKK2 deficiency was sufficient to reduce DEP exposure-induced pulmonary inflammation; *b*) lung epithelial cell--specific IKK2 deficiency nearly abolished DEP exposure--induced systemic insulin resistance and subsequent glucose intolerance; *c*) DEP exposure caused glucose intolerance primarily through induction of hepatic insulin resistance, paralleled by higher hepatic IRS-1 serine phosphorylation and expression of inflammatory markers; and *d*) lung epithelial cell--specific IKK2 deficiency ameliorated DEP exposure--induced hepatic inflammation and insulin resistance. Collectively, our data, which was generated in a transgenic mouse model, indicate that pulmonary inflammation is essential for the pathogenesis of abnormal glucose homeostasis due to exposure to DEP.

The lung is the primary target organ of inhaled ${PM}_{2.5}$, and pulmonary inflammation has long been believed to be crucial in the pathogenesis due to exposure to ${PM}_{2.5}$ ([@c36]). However, except for the time course studies ([@c6]), this notion has not been systemically investigated, primarily due to a lack of appropriate animal models. We previously induced pulmonary inflammation through lung epithelial cell-specific overexpression of constitutively active IKK2 using SPFTC-rtTA and tetO-cre alleles and demonstrated that pulmonary inflammation is sufficient to cause systemic insulin resistance ([@c7]). In the present study, this genetic manipulation strategy was exploited to delete endogenous IKK2 specifically in the lung epithelial cells. The lung epithelial cell--specific recombination of the IKK2 gene ([Figures 1B--1D](#f1){ref-type="fig"}) and the lower number of DEP exposure--associated BALF immune cells and proinflammatory cytokines in KO vs. tgWT mice strongly support the suitability of these mice as a model system for studying the role of pulmonary inflammation in pathogenesis due to exposure to ${PM}_{2.5}$. The specified role of pulmonary IKK2 in the development of ${PM}_{2.5}$ exposure--induced pulmonary inflammation is consistent with the numerous previous studies that have shown that $\text{IKK}2/\text{NF\ -}\kappa B$ signaling pathway is central to the inflammatory response ([@c35]) and several other studies have implicated it in ${PM}_{2.5}$ exposure--induced pulmonary inflammation ([@c10]; [@c20]; [@c30]; [@c32]; [@c33]). To the best of our knowledge, the present study is the first one to show the essential role of IKK2 in induction of pulmonary inflammation by exposure to DEP in living animals, thus providing a valuable animal model for the study of the pathogenic role of pulmonary inflammation in a complex process, such as the one due to exposure to DEP.

Both epidemiological ([@c1]; [@c42]) and toxicological ([@c27]; [@c40]; [@c41]) studies have shown that exposure to ${PM}_{2.5}$ causes insulin resistance and glucose intolerance. Consistent with these studies, the present study reveals that long-term (e.g., 3- to 4-month) exposure to DEP resulted in marked insulin resistance and glucose intolerance in tgWT mice. In contrast, short-term (e.g., 2- to 3-month) exposure to DEP did not cause any significant differences in glucose homeostasis ([Figures 3A--3D](#f3){ref-type="fig"}). This time dependency is consistent with recent epidemiological studies ([@c45]). Notably, we previously showed that exposure to concentrated ambient ${PM}_{2.5}$ rapidly induced abnormalities in glucose homeostasis in diabetic KKAy mice ([@c26]). Taken together, these studies suggest that there may be populations who are potentially susceptible to ${PM}_{2.5}$ exposure, in particular individuals with increased risk for diabetes. Glucose tolerance is collectively determined by circulating insulin level and systemic sensitivity to insulin. The present study demonstrates that exposure to DEP resulted in lower systemic insulin sensitivity but greater glucose-induced insulin secretion in tgWT mice than are found in those exposed to PBS, suggesting that DEP exposure causes glucose intolerance primarily through induction of systemic insulin resistance. Furthermore, we show that DEP exposure was associated with lower insulin signaling in the liver but not in the adipose tissue or skeletal muscle. To our knowledge, the present study is the first one to assess the insulin sensitivity effect of DEP exposure on all three insulin-dependent tissues simultaneously. The liver as the primary target organ for DEP exposure inducing systemic insulin resistance is consistent with our previous study ([@c27]), and lower hepatic insulin sensitivity after exposure to DEP is consistent with several previous studies by others ([@c19]; [@c41]; [@c46]). However, it is noteworthy that we recently showed that, in a mouse model, exposure to concentrated ambient ${PM}_{2.5}$ promoted the inflammation of adipose tissues and decreased their insulin sensitivity ([@c18]). Therefore, further study is needed to verify the effect of ${PM}_{2.5}$ exposure on the insulin sensitivity of adipose tissues.

Another important finding in the present study is the demonstration that ${PM}_{2.5}$ exposure--induced hepatic insulin resistance was accompanied by hepatic inflammation, strongly supporting the hypothesis that the latter may play a crucial role in ${PM}_{2.5}$ exposure inducing hepatic insulin resistance. This finding was further supported by the DEP exposure--associated IRS-1 serine phosphorylation. These data are consistent with previous studies showing that exposure to concentrated ambient ${PM}_{2.5}$ (CAP) resulted in hepatic inflammation and IRS-1 phosphorylation at Ser1101 ([@c46]). More important, the present study extended these findings, revealing markedly higher levels of IRS-1 Ser307 phosphorylation upon exposure to DEP in comparison with levels in mice treated with PBS. IRS-1 phosphorylation at either Ser1101 or Ser307 was shown to inhibit signaling transduction via the insulin receptor (IR) and thus to lead to insulin resistance ([@c8]). Although IRS-1 Ser1101 was shown to be phosphorylated by protein kinase $C\text{-}\theta$ ($\text{PKC}\theta$) and S6 kinase beta-1 (S6K1) in a setting of overnutrition ([@c39]), IRS-1 Ser307 was shown to be phosphorylated by JNK and IKK2 in response to $\text{TNF}\alpha$ treatment ([@c8]). Therefore, phosphorylation of IRS-1 Ser307 is generally believed to be one of the molecular mechanisms for inflammation-induced insulin resistance. In line with the increased IRS-1 Ser307 phosphorylation, the present study demonstrates that DEP exposure was associated with significantly higher phosphorylation of JNK and IKK2, two central regulators of inflammatory responses. Collectively, these data suggest that DEP exposure--induced hepatic insulin resistance may result from a local inflammatory response.

As one of its primary goals, the present study has also provided deep insight into the pathogenesis of hepatic inflammation and consequent insulin resistance due to exposure to ${PM}_{2.5}$. The present data strongly suggest that egress from the pulmonary inflammatory response is central to the development of hepatic inflammation and insulin resistance due to exposure to ${PM}_{2.5}$. Evidence for this role of pulmonary inflammation include our finding that exposure to DEP was associated with significantly higher circulating proinflammatory cytokines, such as $\text{TNF}\alpha$, and IL-6 in tgWT mice. These differences in circulating proinflammatory cytokines are consistent with findings in numerous previous studies ([@c2]; [@c12]). Furthermore, we show that lung epithelial cell--specific IKK2 deficiency seemed to nearly abolish the higher circulating levels of proinflammatory cytokines associated with DEP exposure, such that cytokine levels in DEP-treated mice were similar to those in PBS-treated mice ([Figure 2](#f2){ref-type="fig"}).

Although additional work is needed to pinpoint its role, these findings suggest that in a transgenic mouse model, pulmonary inflammation is essential for the ${PM}_{2.5}$ exposure--induced increases in circulating proinflammatory cytokines. Given the well-established role of proinflammatory cytokines in various liver diseases, including inflammation and the demonstration of marked hepatic inflammation, it can be postulated that ${PM}_{2.5}$ exposure--induced hepatic inflammation may be subsequent to increased circulating proinflammatory cytokines, which in turn results from pulmonary inflammation. In contrast, the marked decrease in KO mice of DEP exposure--induced hepatic inflammation and insulin resistance almost rules out the possibility that extrapulmonary translocation of DEP components plays an important role in this pathogenesis, because no major metabolic change (reflected by BW assessment) was noted in KO mice.

Although the present study furthers our understanding of the mechanism of action of DEP, caution should be taken when extrapolating these results to ambient PM exposure due to the limitations of the present study. First, it should be noted that intratracheal instillation, although routinely used in toxicological investigations due to its multiple advantages, is different from actual human inhalation, particularly in the deposition pattern. This difference may influence not only the distribution of particles in the lung but also the exposure--response relationship ([@c34]; [@c38]). In addition, consistent with previous studies ([@c17]; [@c37]), the present results suggest a proinflammatory action of chronic instillation of PBS in the lung ([Figure 1](#f1){ref-type="fig"}). Because all the experimental groups in this study were treated with PBS, this treatment is not expected to be a confounding factor in the study. However, further study is required to exclude the potential effect of this nonspecific inflammation on the sensitivity of mice to PM ([@c17]). Moreover, although DEP may be the major source of ambient ${PM}_{2.5}$ in some areas, their chemical compositions are generally different. Therefore, further study is warranted to determine the role of pulmonary IKK2 in the development of glucose intolerance due to exposure to ambient ${PM}_{2.5}$. Another factor to note is that the KO mice had marked remaining IKK2 expression in the lung ([Figures 1B--1D](#f1){ref-type="fig"}), which may be due to the presence of nonepithelial cells in the lung or the inefficiency of the cre system. In human lungs, only about one-third of total lung cells were epithelial cells ([@c9]). Therefore, the presence of nonepithelial cells in the lungs was more likely the primary reason for the remaining IKK2 expression in the KO mice. Furthermore, the induced lung epithelial cell--specific knockout of IKK2 ([Figures 1B-1D](#f1){ref-type="fig"}) was verified at the end of the 8-wk doxycycline feeding only. Because the mice were not fed the doxycycline diet beyond those 8 wk, we cannot rule out the possibility that the induced knockout of IKK2 was partly restored during the 4-month PBS/DEP instillation due to the turnover of lung epithelial cells.

Conclusion {#s5}
==========

Our findings suggest that in a transgenic mouse model, an IKK2-dependent pulmonary inflammatory response was essential for the development of abnormal glucose homeostasis due to exposure to DEP.
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